156 related articles for article (PubMed ID: 37285711)
1. Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease.
Dunder L; Salihovic S; Lind PM; Elmståhl S; Lind L
Environ Int; 2023 Jul; 177():107979. PubMed ID: 37285711
[TBL] [Abstract][Full Text] [Related]
2. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease - Results from two independent population-based cohorts and a meta-analysis.
Dunder L; Salihovic S; Varotsis G; Lind PM; Elmståhl S; Lind L
Environ Int; 2023 Nov; 181():108250. PubMed ID: 37832261
[TBL] [Abstract][Full Text] [Related]
4. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
[TBL] [Abstract][Full Text] [Related]
5. Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population.
Salihovic S; Lind L; Larsson A; Lind PM
Environ Int; 2020 Dec; 145():106099. PubMed ID: 32916415
[TBL] [Abstract][Full Text] [Related]
6. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
[TBL] [Abstract][Full Text] [Related]
9. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.
Chang CJ; Barr DB; Ryan PB; Panuwet P; Smarr MM; Liu K; Kannan K; Yakimavets V; Tan Y; Ly V; Marsit CJ; Jones DP; Corwin EJ; Dunlop AL; Liang D
Environ Int; 2022 Jan; 158():106964. PubMed ID: 34735953
[TBL] [Abstract][Full Text] [Related]
10. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
[TBL] [Abstract][Full Text] [Related]
11. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
[TBL] [Abstract][Full Text] [Related]
12. Association between the total plasma isomers of per- and polyfluoroalkyl substances and erythrograms in young and middle-aged Taiwanese populations.
Lin CY; Lee HL; Wang C; Sung FC; Su TC
Ecotoxicol Environ Saf; 2021 Dec; 227():112902. PubMed ID: 34656858
[TBL] [Abstract][Full Text] [Related]
13. Understanding the effects of per- and polyfluoroalkyl substances on early skin development: Role of ciliogenesis inhibition and altered microtubule dynamics.
Zhao M; Yin N; Yang R; Li S; Zhang S; Faiola F
Sci Total Environ; 2024 Feb; 913():169702. PubMed ID: 38163615
[TBL] [Abstract][Full Text] [Related]
14. Exposure to per- and polyfluoroalkyl substances and high-throughput proteomics in Hispanic youth.
Chen JC; Goodrich JA; Walker DI; Liao J; Costello E; Alderete TL; Valvi D; Hampson H; Li S; Baumert BO; Rock S; Jones DP; Eckel SP; McConnell R; Gilliland FD; Aung MT; Conti DV; Chen Z; Chatzi L
Environ Int; 2024 Apr; 186():108601. PubMed ID: 38537583
[TBL] [Abstract][Full Text] [Related]
15. Immune cell profiles associated with human exposure to perfluorinated compounds (PFAS) suggest changes in natural killer, T helper, and T cytotoxic cell subpopulations.
Tursi AR; Lindeman B; Kristoffersen AB; Hjertholm H; Bronder E; Andreassen M; Husøy T; Dirven H; Andorf S; Nygaard UC
Environ Res; 2024 Sep; 256():119221. PubMed ID: 38795951
[TBL] [Abstract][Full Text] [Related]
16. Serum Per- and Polyfluoroalkyl Substances Are Associated with Increased Hearing Impairment: A Re-Analysis of the National Health and Nutrition Examination Survey Data.
Li MC
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32806617
[TBL] [Abstract][Full Text] [Related]
17. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
[TBL] [Abstract][Full Text] [Related]
18. A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS).
Wen ZJ; Wei YJ; Zhang YF; Zhang YF
Arch Toxicol; 2023 May; 97(5):1195-1245. PubMed ID: 36947184
[TBL] [Abstract][Full Text] [Related]
19. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
[TBL] [Abstract][Full Text] [Related]
20. Associations between Per- and Polyfluoroalkyl Substances (PFAS) and Cardiometabolic Biomarkers in Adults of Czechia: The Kardiovize Study.
Maranhao Neto GA; Polcrova AB; Pospisilova A; Blaha L; Klanova J; Bobak M; Gonzalez-Rivas JP
Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
